Gadodiamide T1 relaxivity in brain tissue in vivo is lower than in saline.
Gadodiamide T1 relaxivity in brain tissue in vivo is lower than in saline.
复制标题
体内脑组织中的钆双酰胺 T1 弛豫度低于盐水中。
DOI:
10.1002/mrm.20336
复制
发表时间:
2005
影响因子:
3.3
通讯作者:
Kundel,HaroldL
中科院分区:
文献类型:
--
作者:
Pickup,Stephen;Wood,AndrewKW;Kundel,HaroldL
In vivo measurements of gadodiamide (Gd‐DTPA‐BMA)T1relaxivity were performed at 4.7 T in injured and normal rat brains. Cerebral lesions were induced in nine rats by a localized freezing method.T1maps of the lesions were generated before and after injection of Gd‐DTPA‐BMA (0.1–0.6 mmol/kg). Samples of normal and necrotic brain were collected postmortem; the wet and dry weights were determined, and Gd content was measured by inductively coupled plasma mass spectroscopy. The in vivo relaxivity was determined by a linear fit of a plot of the change in relaxation rate following injection of the contrast agent as a function of Gd content. This analysis yielded a relaxivity in the injured brain of 2.8 sec−1mmol−1kg tissue water at 36°C. The water weight fraction was 0.90 ± SD 0.02 wt/wt in injured brain and 0.79 ± 0.02 in normal brain. Relaxivity measurements were also performed on solutions of Gd‐DTPA‐BMA (0.0–0.6 mmol) and albumin (0–30% wt/wt) in normal saline at room and physiologic temperatures. The relaxivity in the albumin/saline increased with increasing solids content with values of 4.0–4.9 sec−1mmol−1kg at 21°C and 3.4–4.5 sec−1mmol−1kg at 37°C. The relaxivity of the tissues differed significantly from that of the saline solutions of comparable solids content, suggesting that the solids content of a tissue is not the only factor that determines in vivo relaxivity. Magn Reson Med 53:35–40, 2005. © 2004 Wiley‐Liss, Inc.